Search by Drug Name or NDC

    NDC 58657-0454-01 Me NaPhos MB Hyo 1 .12; 81.6; 10.8; 40.8 mg/1; mg/1; mg/1; mg/1 Details

    Me NaPhos MB Hyo 1 .12; 81.6; 10.8; 40.8 mg/1; mg/1; mg/1; mg/1

    Me NaPhos MB Hyo 1 is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Method Pharmaceuticals. The primary component is HYOSCYAMINE SULFATE ANHYDROUS; METHENAMINE; METHYLENE BLUE ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE.

    Product Information

    NDC 58657-0454
    Product ID 58657-454_0c1cc5ba-7438-062d-e063-6294a90ae544
    Associated GPIs 16992004200325
    GCN Sequence Number 066593
    GCN Sequence Number Description methenam/sod phos/mblue/hyoscy TABLET 81.6-.12MG ORAL
    HIC3 W2G
    HIC3 Description ANTIBIOTIC, ANTIBACTERIAL, MISC.
    GCN 28868
    HICL Sequence Number 037115
    HICL Sequence Number Description METHENAMINE/SOD PHOSPH,MONOBASIC/METHYLENE BLUE/HYOSCYAMINE
    Brand/Generic Generic
    Proprietary Name Me NaPhos MB Hyo 1
    Proprietary Name Suffix n/a
    Non-Proprietary Name Urinary Antiseptic Antispasmodic
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength .12; 81.6; 10.8; 40.8
    Active Ingredient Units mg/1; mg/1; mg/1; mg/1
    Substance Name HYOSCYAMINE SULFATE ANHYDROUS; METHENAMINE; METHYLENE BLUE ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
    Labeler Name Method Pharmaceuticals
    Pharmaceutical Class Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]
    DEA Schedule n/a
    Marketing Category UNAPPROVED DRUG OTHER
    Application Number n/a
    Listing Certified Through 2024-12-31

    Package

    NDC 58657-0454-01 (58657045401)

    NDC Package Code 58657-454-01
    Billing NDC 58657045401
    Package 100 TABLET in 1 BOTTLE (58657-454-01)
    Marketing Start Date 2015-12-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 3.58102
    Pricing Unit EA
    Effective Date 2024-01-17
    NDC Description ME-NAPHOS-MB-HYO 1 TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis